Streamlining Hematology Express Scripts Integration for Complex Therapies

Klivira provides a robust solution for hematology express scripts integration, automating the complex prior authorization workflows for high-cost specialty medications and procedures.

Revenue cycle leaders and prior authorization coordinators in hematology face unique challenges managing PBM approvals, particularly for specialty drugs and advanced therapies. The intricate requirements of Express Scripts, now Evernorth Pharmacy, for conditions ranging from hemophilia to hematologic oncology, demand a precision-driven approach to minimize denials and accelerate patient access.

The Challenge of Hematology Prior Authorizations with Express Scripts

Hematology practices frequently encounter Express Scripts (Evernorth Pharmacy) as a key PBM for specialty drugs, including factor concentrates for hemophilia, novel sickle cell disease therapeutics, and advanced CAR-T cell therapies. These high-cost, high-touch medications necessitate detailed clinical documentation and adherence to specific payer policies, often leading to manual burdens and delays in the PA process.

Key Hematology PA Triggers for Express Scripts

  • **Factor Concentrates**: For hemophilia A and B, including prophylaxis and on-demand treatment regimens.
  • **Sickle Cell Disease Therapeutics**: Such as voxelotor (Oxbryta) and crizanlizumab (Adakveo), and emerging gene therapies (Casgevy, Lyfgenia).
  • **Hematologic Oncology Biologics**: For lymphomas, leukemias, and multiple myeloma, often guided by NCCN compendium criteria.
  • **CAR-T Cell Therapies**: Including Yescarta, Kymriah, Breyanzi, Tecartus, Carvykti, and Abecma, requiring extensive prior-line therapy and diagnosis confirmation.
  • **VTE/Anticoagulation Specialty Drugs**: For specific clinical scenarios.
  • **Bone Marrow / Stem Cell Transplant**: Autologous and allogeneic procedures.

Optimizing Express Scripts Workflows for Hematology

Effective hematology express scripts integration requires a system that understands both the clinical nuances of blood disorders and the specific digital submission pathways of a major PBM like Express Scripts. Klivira streamlines this by directly connecting EMR order types with payer portals, facilitating the submission of X12 278 transactions or ePA via NCPDP SCRIPT standards where applicable.

Documentation and Guideline Adherence for Hematology PAs

Klivira's platform incorporates ASH guidelines for hemophilia factor utilization and NCCN guidelines for hematologic oncology, proactively flagging documentation requirements. For CAR-T therapies, this includes ensuring the submission of diagnosis confirmation and prior-line therapy details. This ensures that essential data like factor levels, joint health status, and bleeding episode tracking are complete before submission, mitigating common denial reasons.

Klivira's Capabilities for Hematology Express Scripts Integration

  • Automated extraction of relevant clinical data from EMRs for Express Scripts submissions.
  • Pre-submission logic informed by ASH and NCCN guidelines for hematologic conditions.
  • Streamlined submission of PAs for high-cost drugs like factor concentrates and sickle cell therapies.
  • Dedicated workflows for complex CAR-T cell therapy and bone marrow transplant PAs.
  • Real-time status tracking and appeals management for Express Scripts authorizations.

EMR and Payer Touchpoints in Hematology PA

Our integration solution connects directly with leading EMR systems via SMART on FHIR, capturing order types for specialty drugs, advanced imaging, and transplant procedures. This ensures that data points critical for Express Scripts' review, such as specific lab results, treatment plans, and clinical notes, are seamlessly transferred, reducing manual data entry and potential errors.

Frequently asked questions

How does Klivira handle the specific documentation requirements for hemophilia factor concentrates with Express Scripts?

Klivira's platform is designed to track and prompt for specific documentation required by ASH guidelines and Express Scripts policies, including factor levels, joint health assessments, and bleeding episode logs. This ensures that all necessary clinical data is captured and submitted accurately, supporting both prophylaxis and on-demand treatment requests.

Can Klivira assist with prior authorizations for novel sickle cell disease therapies via Express Scripts?

Yes, Klivira supports the prior authorization process for novel sickle cell disease therapeutics like voxelotor (Oxbryta) and crizanlizumab (Adakveo), as well as emerging gene therapies. Our system incorporates the specific clinical criteria and documentation often requested by PBMs like Express Scripts for these high-cost specialty drugs.

What kind of EMR integration does Klivira offer for hematology practices dealing with Express Scripts PAs?

Klivira offers robust EMR integration, often utilizing SMART on FHIR standards, to connect directly with your existing systems. This allows for automated data extraction from patient charts, orders, and clinical notes, ensuring that all necessary information for Express Scripts prior authorization requests is accurately and efficiently transferred without manual intervention.

How does Klivira address common denial reasons from Express Scripts for hematologic oncology drugs?

Our platform incorporates NCCN-compendium aware policy logic to ensure that submissions for hematologic oncology drugs align with payer criteria. By proactively identifying and addressing potential documentation gaps, such as missing prior-line therapy details for CAR-T cells, Klivira helps mitigate common denial reasons from Express Scripts.

Does Klivira support electronic prior authorization (ePA) submissions to Express Scripts for hematology?

Yes, Klivira supports electronic prior authorization (ePA) submissions to Express Scripts, leveraging industry standards like NCPDP SCRIPT where available. This digital approach accelerates the submission process, reduces administrative burden, and provides faster turnaround times compared to traditional fax or portal-based methods.

Related coverage

Other hematology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo